{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"institution":[{"name":"bioRxiv"}],"indexed":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T18:42:27Z","timestamp":1785436947436,"version":"3.56.0"},"posted":{"date-parts":[[2026,1,7]]},"group-title":"Cell Biology","reference-count":40,"publisher":"openRxiv","license":[{"start":{"date-parts":[[2026,1,7]],"date-time":"2026-01-07T00:00:00Z","timestamp":1767744000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"crossref","award":["R01DK114233"],"award-info":[{"award-number":["R01DK114233"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"crossref","award":["UG3DK142188"],"award-info":[{"award-number":["UG3DK142188"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Breakthrough T1D","award":["3-SRA-2023-1295-S-B"],"award-info":[{"award-number":["3-SRA-2023-1295-S-B"]}]},{"id":[{"id":"https:\/\/ror.org\/035yf7a66","id-type":"ROR","asserted-by":"publisher"}]},{"name":"Anita Palmer Corbin Trust"},{"id":[{"id":"https:\/\/ror.org\/04cf69335","id-type":"ROR","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"accepted":{"date-parts":[[2026,1,7]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n                <jats:sec>\n                  <jats:title>Introduction<\/jats:title>\n                  <jats:p>Pancreatic islet transplantation is a promising therapeutic strategy to restore insulin independence in patients with type 1 diabetes mellitus. In addition to primary human islets, human pluripotent stem cell-derived islets have shown clinical promise. However, optimizing transplantation sites and improving methods for standardized islet dosing and post-transplant graft localization are key limitations. The subcutaneous space offers an alternative site for transplantation due to its accessibility and minimally invasive nature; nevertheless, poor vascularization and difficulty locating engrafted islets limit its experimental utility. The use of dithizone, a zinc-chelating dye that selectively binds the high intracellular zinc concentrations of insulin-producing \u03b2-cells, may enable rapid graft localization through selective staining. Here, we investigate whether dithizone staining can reliably localize transplanted islet grafts within the subcutaneous space of murine models.<\/jats:p>\n                <\/jats:sec>\n                <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>SC-islets were generated from HUES8 stem cells and functionally validated using glucose-stimulated insulin secretion. Islet volume was standardized prior to transplantation using automated islet equivalent quantification with the BioRep Islet Cell Counter. Approximately 4,000 islet equivalents of either SC-islets or primary human islets were transplanted into the subcutaneous space of immunodeficient mice. Graft function was assessed longitudinally via blood glucose monitoring, glucose tolerance testing, and human C-peptide measurements. Four weeks post-transplantation, dithizone staining was applied to harvested skin tissue to localize islet grafts, and immunohistochemical validation was performed.<\/jats:p>\n                <\/jats:sec>\n                <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>\n                    Automated quantification of islet equivalents enabled consistent dosing across transplantation groups. Transplanted islets maintained function\n                    <jats:italic>in vivo<\/jats:italic>\n                    , as demonstrated by reduced blood glucose levels, preserved glucose tolerance, and detectable human C-peptide. Dithizone staining produced clear and selective red labeling of insulin-producing \u03b2-cell grafts within the subcutaneous tissue, enabling reliable localization and recovery of engrafted islets. Immunohistochemical analyses confirmed the presence of insulin-expressing cells at isolated islet grafts.\n                  <\/jats:p>\n                <\/jats:sec>\n                <jats:sec>\n                  <jats:title>Discussion<\/jats:title>\n                  <jats:p>Dithizone staining is a rapid, cost-effective approach to identify subcutaneous islet grafts and enables downstream analyses, addressing a significant limitation in islet transplantation research. When combined with standardized pre-transplant islet quantification, this approach provides a cohesive and reproducible framework for evaluating subcutaneous islet transplantation. Future studies could complement these results by assessing the potential effects of dithizone exposure and exploring its applicability across other transplantation sites and imaging modalities.<\/jats:p>\n                <\/jats:sec>","DOI":"10.64898\/2026.01.06.697969","type":"posted-content","created":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T00:10:16Z","timestamp":1767831016000},"source":"Crossref","is-referenced-by-count":0,"title":["Optimizing Post-Transplantation Detection of Subcutaneously Transplanted Islets Using Dithizone Staining"],"prefix":"10.64898","author":[{"given":"James","family":"Lu","sequence":"first","affiliation":[{"name":"Division of Endocrinology, Metabolism and Lipid Research, Washington University School of Medicine, St. Louis, MO, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew","family":"Ishahak","sequence":"additional","affiliation":[{"name":"Division of Endocrinology, Metabolism and Lipid Research, Washington University School of Medicine, St. Louis, MO, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marlie M.","family":"Maestas","sequence":"additional","affiliation":[{"name":"Division of Endocrinology, Metabolism and Lipid Research, Washington University School of Medicine, St. Louis, MO, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0426-3492","authenticated-orcid":false,"given":"Jeffrey R.","family":"Millman","sequence":"additional","affiliation":[{"name":"Division of Endocrinology, Metabolism and Lipid Research, Washington University School of Medicine, St. Louis, MO, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"54368","reference":[{"issue":"7","key":"2026010808550847000_2026.01.06.697969v1.1","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.2337\/db25-0037","article-title":"Advances in Cell Replacement Therapies for Diabetes","volume":"74","year":"2025","journal-title":"Diabetes"},{"key":"2026010808550847000_2026.01.06.697969v1.2","doi-asserted-by":"crossref","first-page":"631463","DOI":"10.3389\/fendo.2021.631463","article-title":"Stem Cell-Based Clinical Trials for Diabetes Mellitus","volume":"12","year":"2021","journal-title":"Front Endocrinol (Lausanne"},{"key":"2026010808550847000_2026.01.06.697969v1.3","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM200007273430401"},{"key":"2026010808550847000_2026.01.06.697969v1.4","doi-asserted-by":"crossref","unstructured":"Bottino R , Knoll MF , Knoll CA , Bertera S , Trucco MM . The Future of Islet Transplantation Is Now. Front Med [Internet]. 2018 July 13 [cited 2025 Nov 20];5. Available from: https:\/\/www.frontiersin.org\/journals\/medicine\/articles\/10.3389\/fmed.2018.00202\/full","DOI":"10.3389\/fmed.2018.00202"},{"issue":"2","key":"2026010808550847000_2026.01.06.697969v1.5","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/j.stemcr.2018.12.012","article-title":"Acquisition of Dynamic Function in Human Stem Cell-Derived \u03b2 Cells","volume":"12","year":"2019","journal-title":"Stem Cell Reports"},{"key":"2026010808550847000_2026.01.06.697969v1.6","doi-asserted-by":"publisher","DOI":"10.1038\/s41556-018-0271-4"},{"key":"2026010808550847000_2026.01.06.697969v1.7","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2014.09.040"},{"key":"2026010808550847000_2026.01.06.697969v1.8","doi-asserted-by":"publisher","DOI":"10.1038\/s41587-020-0430-6"},{"key":"2026010808550847000_2026.01.06.697969v1.9","doi-asserted-by":"publisher","DOI":"10.1038\/nbt.3033"},{"issue":"9","key":"2026010808550847000_2026.01.06.697969v1.10","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1056\/NEJMoa2506549","article-title":"Stem Cell-Derived, Fully Differentiated Islets for Type 1 Diabetes","volume":"393","year":"2025","journal-title":"N Engl J Med"},{"key":"2026010808550847000_2026.01.06.697969v1.11","doi-asserted-by":"publisher","DOI":"10.1016\/j.stem.2023.04.002"},{"key":"2026010808550847000_2026.01.06.697969v1.12","doi-asserted-by":"publisher","DOI":"10.1038\/s41574-024-01029-0"},{"key":"2026010808550847000_2026.01.06.697969v1.13","doi-asserted-by":"publisher","DOI":"10.1093\/stcltm\/szab013"},{"key":"2026010808550847000_2026.01.06.697969v1.14","doi-asserted-by":"crossref","unstructured":"Pomposelli T , Schuetz C , Wang P , Yamada K . A Strategy to Simultaneously Cure Type 1 Diabetes and Diabetic Nephropathy by Transplant of Composite Islet-Kidney Grafts. Front Endocrinol (Lausanne). 2021 May 12;12:632605.","DOI":"10.3389\/fendo.2021.632605"},{"issue":"10205","key":"2026010808550847000_2026.01.06.697969v1.15","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1016\/S0140-6736(19)31334-0","article-title":"Advances in \u03b2-cell replacement therapy for the treatment of type 1 diabetes","volume":"394","year":"2019","journal-title":"Lancet"},{"key":"2026010808550847000_2026.01.06.697969v1.16","doi-asserted-by":"publisher","DOI":"10.1126\/science.abh1657"},{"key":"2026010808550847000_2026.01.06.697969v1.17","doi-asserted-by":"publisher","DOI":"10.1038\/nbt.3211"},{"issue":"1","key":"2026010808550847000_2026.01.06.697969v1.18","doi-asserted-by":"crossref","first-page":"14731","DOI":"10.1038\/s41598-022-19189-2","article-title":"Development of a novel method for measuring tissue oxygen pressure to improve the hypoxic condition in subcutaneous islet transplantation","volume":"12","year":"2022","journal-title":"Sci Rep"},{"key":"2026010808550847000_2026.01.06.697969v1.19","doi-asserted-by":"publisher","DOI":"10.1093\/stcltm\/szab013"},{"issue":"1","key":"2026010808550847000_2026.01.06.697969v1.20","doi-asserted-by":"crossref","first-page":"8617","DOI":"10.1038\/s41598-021-88166-y","article-title":"Optimal allogeneic islet dose for transplantation in insulin-dependent diabetic Macaca fascicularis monkeys","volume":"11","year":"2021","journal-title":"Sci Rep"},{"key":"2026010808550847000_2026.01.06.697969v1.21","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM200007273430401"},{"key":"2026010808550847000_2026.01.06.697969v1.22","doi-asserted-by":"publisher","DOI":"10.1177\/0963689718779898"},{"key":"2026010808550847000_2026.01.06.697969v1.23","doi-asserted-by":"publisher","DOI":"10.1007\/BF02581331"},{"issue":"5","key":"2026010808550847000_2026.01.06.697969v1.24","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1007\/s00592-012-0375-4","article-title":"A replacement for islet equivalents with improved reliability and validity","volume":"50","year":"2013","journal-title":"Acta Diabetol"},{"key":"2026010808550847000_2026.01.06.697969v1.25","doi-asserted-by":"publisher","DOI":"10.3727\/096368916x691655"},{"issue":"2","key":"2026010808550847000_2026.01.06.697969v1.26","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/j.stemcr.2018.12.012","article-title":"Acquisition of Dynamic Function in Human Stem Cell-Derived \u03b2 Cells","volume":"12","year":"2019","journal-title":"Stem Cell Reports"},{"key":"2026010808550847000_2026.01.06.697969v1.27","doi-asserted-by":"publisher","DOI":"10.1634\/stemcells.20-4-284"},{"key":"2026010808550847000_2026.01.06.697969v1.28","doi-asserted-by":"publisher","DOI":"10.1038\/s41587-020-0430-6"},{"issue":"7","key":"2026010808550847000_2026.01.06.697969v1.29","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.2337\/db25-0037","article-title":"Advances in Cell Replacement Therapies for Diabetes","volume":"74","year":"2025","journal-title":"Diabetes"},{"key":"2026010808550847000_2026.01.06.697969v1.30","doi-asserted-by":"crossref","unstructured":"Li Q , Liu R , Lin Z , Zhang X , Silva IG , Pollock SD , et al. Cyborg islets: implanted flexible electronics reveal principles of human islet electrical maturation. bioRxiv. 2024 Mar 20;2024.03.18.585551.","DOI":"10.1101\/2024.03.18.585551"},{"key":"2026010808550847000_2026.01.06.697969v1.31","doi-asserted-by":"publisher","DOI":"10.1088\/1758-5090\/9\/1\/015002"},{"key":"2026010808550847000_2026.01.06.697969v1.32","doi-asserted-by":"publisher","DOI":"10.1126\/science.abh1657"},{"key":"2026010808550847000_2026.01.06.697969v1.33","doi-asserted-by":"publisher","DOI":"10.1210\/er.2018-00154"},{"issue":"10205","key":"2026010808550847000_2026.01.06.697969v1.34","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1016\/S0140-6736(19)31334-0","article-title":"Advances in \u03b2-cell replacement therapy for the treatment of type 1 diabetes","volume":"394","year":"2019","journal-title":"Lancet"},{"key":"2026010808550847000_2026.01.06.697969v1.35","doi-asserted-by":"crossref","unstructured":"Differential Function and Maturation of Human Stem Cell-Derived Islets After Transplantation | Stem Cells Translational Medicine | Oxford Academic [Internet]. [cited 2025 Nov 20]. Available from: https:\/\/academic.oup.com\/stcltm\/article\/11\/3\/322\/6549674","DOI":"10.1093\/stcltm\/szab013"},{"issue":"10","key":"2026010808550847000_2026.01.06.697969v1.36","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1093\/stcltm\/szae059","article-title":"Recent progress in modeling and treating diabetes using stem cell-derived islets","volume":"13","year":"2024","journal-title":"Stem Cells Transl Med"},{"key":"2026010808550847000_2026.01.06.697969v1.37","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.adg5794"},{"issue":"1","key":"2026010808550847000_2026.01.06.697969v1.38","doi-asserted-by":"crossref","first-page":"100879","DOI":"10.1016\/j.xcrm.2022.100879","article-title":"Engineering human stem cell-derived islets to evade immune rejection and promote localized immune tolerance","volume":"4","year":"2023","journal-title":"Cell Reports Medicine"},{"key":"2026010808550847000_2026.01.06.697969v1.39","doi-asserted-by":"publisher","DOI":"10.1038\/s41587-023-01784-x"},{"key":"2026010808550847000_2026.01.06.697969v1.40","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.abm9881"}],"container-title":[],"original-title":[],"link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.64898\/2026.01.06.697969","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,24]],"date-time":"2026-06-24T05:15:11Z","timestamp":1782278111000},"score":1,"resource":{"primary":{"URL":"http:\/\/biorxiv.org\/lookup\/doi\/10.64898\/2026.01.06.697969"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,7]]},"references-count":40,"URL":"https:\/\/doi.org\/10.64898\/2026.01.06.697969","relation":{"is-preprint-of":[{"id-type":"doi","id":"10.1186\/s44330-026-00075-6","asserted-by":"subject"}]},"subject":[],"published":{"date-parts":[[2026,1,7]]},"subtype":"preprint"}}